Celanese Declares Force Majeure on Vinyl Acetate Monomer in US
Celanese Corporation (CE) announced that as a result of Hurricane Harvey’s impact on Celanese’s operations, suppliers and service providers in the Texas Gulf Coast, Celanese is temporarily unable to supply the vinyl acetate monomer (VAM) needs of its customers in the Americas.
Celanese is continuing to assess the regional and global impact of this force majeure event, and given that this is a rapidly developing situation, Celanese cannot provide any specific details or timing of the full impact to all customers.
Looking for chemical products? Let suppliers reach out to you!
You May Interested In
2026-07-16
-
Fine Chemicals Industry Overview Dec.2025
Insight into Structural Shifts, Capturing Long-Term Value in Fine Chemicals. Available for Permanent Download.Published in: Jan. 2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Dow and Celanese Retreat: European and Korean Cutbacks as China Expands
-
Celanese to Close Acetate Tow Plant in Lanaken, Belgium by 2026
-
Celanese Partners with Cloverdale Paint to Deliver Sustainable Coatings Solutions
-
Celanese Opens Electronic Ink and Pastes Lab in Shenzhen, China
-
Celanese expands Shanghai Pudong Technology Center
-
Celanese Opens Technology Center and Shared Services Center in India
-
Celanese announces strategic milestone for acetyl chain business in China
-
Celanese launches new polyamide solution for electric vehicle components
-
Celanese completes acquisition of most of DuPont M&M businesses
-
DuPont to Sell Transportation And Materials Division to Celanese for $11 Billion
Recommend Reading
-
Ineos Invests £30m to Reduce Emissions at Hull Site by 75%
-
Clariant and Shanghai Electric Partner to Advance Biomass-Based Green Methanol in China
-
Toray Supplies Reverse Osmosis Membranes to Saudi Arabian Desalination Plant
-
Kemira Acquires AquaBlue
-
Arkema's New Singapore Plant Commences Operations, Tripling Polyamide Capacity
-
This week, the soda ash market in China has been operating weakly
-
Bristol Myers’ Reblozyl Misses Main Goal in Cancer Anemia Study $1.77 Billion Drug Faces Setback but Shows Some Benefits
-
Cost and Supply Resonance Drives Up Prices—Melamine Market Rises Strongly
-
MTBE Market Prices Narrowly Decline
-
Sanofi’s $2.2 Billion Dynavax Acquisition: Why Big Pharma Is Rebuilding the Global Vaccine Order